PRK2 Activators
PRK2 Activators are a diverse set of compounds that enhance the kinase activity of PRK2 through multiple signaling pathways. Compounds like Phorbol 12-myristate 13-acetate (PMA) and Ionomycin work by activating PKC, which can directly phosphorylate PRK2, leading to enhanced downstream signaling. Forskolin and its analogs 8-Bromo-cAMP and Dibutyryl-cAMP (db-cAMP) elevate intracellular cPRK2 Activators are a diverse set of compounds that enhance the kinase activity of PRK2 through multiple signaling pathways. Compounds like Phorbol 12-myristate 13-acetate (PMA) and Ionomycin work by activating PKC, which can directly phosphorylate PRK2, leading to enhanced downstream signaling. Forskolin and its analogs 8-Bromo-cAMP and Dibutyryl-cAMP (db-cAMP) elevate intracellular cAMP levels, activating PKA, which can phosphorylate and enhance PRK2 activity. This enhancement facilitates PRK2's role in essential cellular functions, including the MAPK/ERK pathway, which is pivotal for cell division and differentiation. Isoproterenol, by acting as a beta-adrenergic agonist, also raises cAMP levels, indirectly promoting PRK2 activity through PKA-mediated phosphorylation. EGCG, by inhibiting competitive kinases, may allow PRK2 to phosphorylate targets more effectively, thus enhancing its functional role in signaling pathways.
Calphostin C and Go 6976, as selective PKC inhibitors, may enhance PRK2 activity by reducing competition from PKC, allowing PRK2 to play a more dominant role in specific signaling cascades. Chelerythrine supports PRK2 activity by a similar mechanism, reducing PKC-mediated phosphorylation events, which could otherwise overshadow PRK2's function. H-89, although a PKA inhibitor, could lead to a compensatory increase in PRK2 activity, highlighting the complex interplay between cellular kinases. Similarly, Bisindolylmaleimide I (BIM) inhibits PKC, potentially allowing for enhanced PRK2 activation by shifting the balance of cellular signaling. Together, these PRK2 Activators provide a multifaceted approach to augmenting the kinase's activity, affecting various aspects of cellular signaling and function without directly increasing the protein's expression levels.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which in turn can phosphorylate PRK2. This phosphorylation enhances PRK2's kinase activity, leading to the activation of downstream signaling pathways such as the MAPK/ERK pathway. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, increasing cAMP levels, which can lead to the activation of PKA. PKA can phosphorylate PRK2, enhancing its kinase activity and the phosphorylation of downstream targets. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Bromoadenosine 3',5'-cyclic monophosphate is a cell-permeable cAMP analog that activates PKA. PKA activation can lead to PRK2 phosphorylation and activation, enhancing its role in signaling cascades such as the regulation of cell motility. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which can activate calcium-sensitive PKC isoforms. These PKC isoforms can then phosphorylate and activate PRK2. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is another cell-permeable cAMP analog that mimics the action of cAMP in activating PKA. The activation of PKA can lead to subsequent phosphorylation and activation of PRK2. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is known to inhibit certain types of kinases, potentially reducing competition for substrates with PRK2. This can indirectly enhance PRK2 activity by allowing it to phosphorylate its substrates more effectively. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that can increase cAMP production, thereby activating PKA. PKA, in turn, can enhance PRK2 activity by phosphorylation. | ||||||